NOISESaved copy
Coverage history

Assembled by NOISE.

Saved report copy

Recorded

FDA weighs public health adviser and cancer-care CEO for leadership roles

The Trump administration is considering HHS senior adviser Sara Brenner and Jeff Vacirca, CEO of New York Cancer & Blood Specialists, for leadership roles at the FDA, Bloomberg reported; no final decisions have been made. The agency’s next leaders will face efforts to speed clinical trials and overhaul reviews of rare-disease drugs. The search follows the withdrawal of Heidi Overton’s commissioner nomination, while several top jobs are vacant and acting FDA leader Kyle Diamantas is expected to leave by year-end.